Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market
By Ludwig Burger and Maggie Fick FRANKFURT (Reuters) – Novo Nordisk has launched blockbuster weight-loss drug Wegovy in Germany, its first big European market, hoping Germans will pay hundreds of euros out of pocket for a drug that public health insurance plans are so far barred from covering. The drug, shown to help patients reduce …
Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market Read More »










